Evidence map›Paper›PMID 38514890›Full record

ArticleNature immunology2024

Author Correction: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cell.

Yulong Gao, Fernando Souza-Fonseca-Guimaraes, Tobias Bald, Susanna S Ng, Arabella Young, Shin Foong Ngiow, Jai Rautela, Jasmin Straube, Nic Waddell, Stephen J Blake and 14 more

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 8 institutions in 4 countries.

Yulong Gao *Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
Fernando Souza-Fonseca-Guimaraes *Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
Tobias BaldImmunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
Susanna S NgImmunology and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
Arabella YoungImmunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
Shin Foong NgiowImmunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
Jai RautelaMolecular Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology and The University of Melbourne, Parkville, Victoria, Australia.
Jasmin StraubeMedical Genomics, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
Nic WaddellMedical Genomics, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
Stephen J BlakeCancer Immunoregulation and Immunotherapy, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
Juming YanSchool of Medicine, The University of Queensland, Herston, Queensland, Australia.
Laurent BartholinUniversité Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon, Lyon, France.
Jason S LeeControl of Gene Expression Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
Eric VivierCentre d'Immunologie de Marseille-Luminy, Aix Marseille Université, INSERM, CNRS, Marseille, France.
Kazuyoshi TakedaDivision of Cell Biology, Biomedical Research Center and Department of Biofunctional Microbiota, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo, Japan.
Meriem MessaoudeneINSERM U1015, Gustave Roussy Cancer Campus, Villejuif, France.
Laurence ZitvogelGustave Roussy Cancer Campus, Villejuif, France.
Michele W L TengSchool of Medicine, The University of Queensland, Herston, Queensland, Australia.
Gabrielle T BelzMolecular Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology and The University of Melbourne, Parkville, Victoria, Australia.
Christian R EngwerdaImmunology and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
Nicholas D HuntingtonMolecular Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology and The University of Melbourne, Parkville, Victoria, Australia.
Kyohei NakamuraImmunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
Michael HölzelUnit for RNA Biology, Department of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany.
Mark J SmythImmunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. mark.smyth@qimrberghofer.edu.au.
QIMR Berghofer Medical Research Institute · AUInserm · FRUniversity of Melbourne · AUUniversity of Queensland · AUWalter and Eliza Hall Institute of Medical Research · AUBicêtre Hospital · FRJuntendo University · JPUniversity of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38514890
OpenAlexW4393044977

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.